Quick Takeaways
- Capital Research Global Investors filed SCHEDULE 13G/A for CONMED Corp. Common Stock (CNMD).
- Disclosed ownership: 3.3%.
- Date of event: 30 Sep 2025.
Capital Research Global Investors - 30 Sep 2025 SCHEDULE 13G/A Report for CONMED Corp. Common Stock (CNMD)
- Filing Manager
- Capital Research Global Investors
- Reporting Manager
- Capital Research Global Investors
- Security
- CONMED Corp. Common Stock
- Symbol
- CNMD
- Shares outstanding
- 31,294,939 shares
- Disclosed Ownership
- 1,032,733 shares
- Ownership
- 3.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Nov 2025, 10:29:34 UTC
- Date of event
- 30 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Capital Research Global Investors disclosed 3.3% ownership in CONMED Corp. Common Stock (CNMD) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Nov 2025, 10:29.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Capital Research Global Investors | 3.3% | 1,032,733 | 1,032,733 | 0 | Jae Won Chung | Vice President and Senior Counsel II, Capital Research and Management Company |